Biosign Flu A+B Rapid Test Kit, 25 test kit by Germaine Labs BSP-510-25

An In vitro rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab and nasal aspirate/wash specimens.

Features:

• Differentiates between Influenza Type A and B, on a single test device
• Produces results in 10 to 15 minutes
• Each test device includes built-in controls
• Each kit comes with external controls
• Meets FDA performance criteria for influenza tests stated in code 21 CFR 866.3328
• CLIA Complexity: Moderate complexity when used with nasal wash/aspirate samples
• CLIA Waived when used with nasal and nasopharyngeal swabs

Intended for physician office use

Expected expiration - 12-18 month expiration dating window

18 kits per case